B. Modell et al., Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry, BR MED J, 320(7231), 2000, pp. 337-341
Citations number
19
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Objective National audit of informed choice in antenatal screening for thal
assaemia.
Design Audit from the UK Confidential Enquiry into Counselling for Genetic
Disorders.
Setting Thalassaemia module of the UK Confidential Enquiry into Counselling
for Genetic Disorders.
Subjects 138 of 156 couples who had had a pregnancy affected by a major bet
a thalassaemia from 1990 to 1994.
Main outcome measures How and when genetic risk was identified for each cou
ple, and whether and when prenatal diagnosis was offered.
Results Risk was detected by screening before or during the first pregnancy
in 49% (68/138) of couples and by diagnosis of an affected child in 28% (3
8/138) of couples. Prenatal diagnosis was offered in 69% (274/400) of pregn
ancies, ranging from 94% (122/130) fur British Cypriots to 54% (80/149) for
British Pakistanis and from 90% in the south east of England to 39% in the
West Midlands. Uptake of prenatal diagnosis was 80% (216/274), ranging fro
m 98% (117/120) among British Cypriots in either the first or second trimes
ter to 73% (35/48) among British Pakistanis in the first trimester and 39%
(11/28) in the second trimester. A demonstrable service failure occurred in
28% (110/400) of pregnancies, including 110 of 126 where prenatal diagnosi
s was not offered and 48 of 93 that ended with an affected liveborn infant.
Conclusion Although antenatal screening and counselling fur haemoglobin dis
orders are standard practices in the United Kingdom, they are delivered ina
dequately and inequitably. An explicit national policy is needed, aiming to
make prenatal diagnosis in the first trimester available to all couples an
d including ongoing national audit.